학술논문

Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study
Document Type
article
Author
Holbrook, Janet TSugar, Elizabeth ABurke, Alyce EVitale, Albert TThorne, Jennifer EDavis, Janet LJabs, Douglas AJaffe, Glenn JBranchaud, BrendaHahn, PaulKoreen, LarryLad, Eleonora MLin, PhoebeMartel, Joseph NissimSerrano, NehaSkalak, CindyVajzovic, LejlaBaer, ClaxtonBryant, JoyceChavala, SaiCusick, MichaelDay, ShelleyDayani, PouyaEhlers, JustisKesen, MugeLee, AnnieMelamud, AlexQureshi, Jawad AScott, Adrienne WilliamsSee, Robert FShuler, Robert KWood, MeganYeh, StevenFernandes, AlcidesGibbs, DeborahLeef, DonnaMartin, Daniel FSrivastava, SunilDunn, James PBegum, HosneBoring, JeffBrotherson, Kristen LBurkholder, BrynButler, Nicholas JCain, DennisCook, Mary AEmmert, DavidGraul, Janis RHerring, MarkLaing, AshleyLeung, Theresa GMahon, Michael CMoradi, AhmafrezaNwankwo, AntoniaOstheimer, Trucian LReed, TerryArnold, EllenBarnabie, Patricia MBelair, Marie-LynnBolton, Stephen GBrodine, Joseph BBrown, Diane MBrune, Lisa MGalor, AnatGan, TheresaJacobowitz, AdamKapoor, MeeraKedhar, SanjayKim, StephenLeder, Henry ALivingston, Alison GMorton, YavetteNolan, KistenPeters, George BSoto, PriscillaStevenson, RicardoTarver-Carr, MichelleWang, YueFoster, C StephenAnesi, Stephen DBruner, LindaCeron, OlgaHinkle, David MPersons, NancyWentworth, BaileyAcevedo, SarahAnzaar, FahdCesca, TomContero, AngelicaFitzpatrick, KayleighGoronga, FaithJohnson, JyothirLebron, Karina QMarvell, DanielleMorgan, ChandraPatel, NitaPinto, JenniferSiddique, Sana SSprague, JanetYilmaz, Taygan
Source
Subject
Clinical Trials and Supportive Activities
Brain Disorders
Eye Disease and Disorders of Vision
Bioengineering
Clinical Research
Prevention
Neurosciences
Eye
Adolescent
Adult
Aged
Aged
80 and over
Drug Implants
Equipment Failure
Female
Fluocinolone Acetonide
Follow-Up Studies
Foreign-Body Migration
Glucocorticoids
Humans
Intravitreal Injections
Male
Middle Aged
Postoperative Complications
Reoperation
Risk Factors
Time Factors
Uveitis
Visual Acuity
Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group
Clinical Sciences
Opthalmology and Optometry
Public Health and Health Services
Ophthalmology & Optometry
Language
Abstract
PurposeTo describe fluocinolone acetonide implant dissociations in the Multicenter Uveitis Steroid Treatment (MUST) Trial.DesignRandomized clinical trial with extended follow-up.MethodsReview of data collected on the first implant in the eye(s) of participants. Dissociation was defined as the drug pellet no longer being affixed to the strut and categorized as spontaneous or surgically related.ResultsA total of 250 eyes (146 patients) had at least 1 implant placed. Median follow-up time after implant placement was 6 years (range 0.5-9.2 years). Thirty-four dissociations were reported in 30 participants. There were 22 spontaneous events in 22 participants; 6-year cumulative risk of a spontaneous dissociation was 4.8% (95% confidence interval [CI]: 2.4%-9.1%). The earliest event occurred 4.8 years after placement. Nine of 22 eyes with data had a decline in visual acuity ≥5 letters temporally related to the dissociation. Thirty-nine implant removal surgeries were performed, 33 with replacement. Twelve dissociations were noted during implant removal surgeries in 10 participants (26%, 95% CI 15%-48%); 5 of these eyes had a decline in visual acuity ≥5 letters after surgery. The time from implant placement to removal surgery was longer for the surgeries at which dissociated implants were identified than for those without one (5.7 vs 3.7 years, P < .001). Overall, visual acuity declined 15 or more letters from pre-implant values in 22% of affected eyes; declines were frequently associated with complications of uveitis or its treatment.ConclusionThere is an increasing risk of dissociation of Retisert implants during follow-up; the risk is greater with removal/exchange surgeries, but the risk of both spontaneous and surgically related events increases with longevity of the implants. In 22% of affected eyes visual acuity declined by 15 letters. In the context of eyes with moderate to severe uveitis for years, this rate is not unexpected.